We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Altria vs. Philip Morris: Which Stock Smokes Out Better Returns?
Read MoreHide Full Article
Key Takeaways
Altria's on! shipments rose 26.5% in Q2, lifting oral tobacco share to 8.7% and boosting margins.
Philip Morris lifted 2025 EPS guidance to $7.43-$7.56, targeting 13-15% year-over-year growth.
Philip Morris achieved $500M in cost savings in H1 2025, advancing toward a $2B efficiency goal.
Altria Group, Inc. ((MO - Free Report) ) and Philip Morris International Inc. ((PM - Free Report) ) stand as two of the most recognized names in the global tobacco industry. While Altria primarily operates within the United States, Philip Morris International has built its dominance outside the United States. Both companies are rooted in the manufacture and sale of cigarettes, smokeless tobacco and increasingly, next-generation reduced-risk products aimed at adapting to shifting consumer preferences and regulatory pressures.
The tobacco industry itself is undergoing a major transformation, shaped by declining cigarette volumes, rising health awareness and evolving regulatory frameworks. Companies like MO and PM are not only competing on brand strength but also on their ability to innovate through alternatives such as heated tobacco and nicotine pouches.
One-Year Price Performance
Image Source: Zacks Investment Research
The Case for Altria
A key driver of Altria’s investment appeal is its resilient earnings growth. In the second quarter of 2025, adjusted earnings per share (EPS) rose 8.3% year over year to $1.44, supported by higher pricing, cost efficiencies and share repurchases. Revenues net of excise taxes held firm at $5.29 billion, reinforcing portfolio stability. Based on the performance, management raised the lower end of its 2025 adjusted EPS guidance to $5.35-$5.45, representing a growth rate of 3% to 5%.
Momentum in the oral tobacco segment remains a standout catalyst, led by the on! nicotine pouch brand. Shipments of on! rose 26.5% to 52.1 million cans in the second quarter. on! now holds 8.7% retail share of the total U.S. oral tobacco market, supported by digital marketing and brand activations that improved consumer awareness. This success drove a 10.9% increase in adjusted operating income and a margin expansion of 310 bps to 68.7%, underscoring Altria’s smoke-free growth strategy.
Meanwhile, Altria’s smokeable products segment continues to demonstrate resilience, driven by strong pricing and disciplined brand management. The adjusted operating income rose 4.2% in the second quarter, with margins expanding 290 bps to 64.5%. Marlboro maintained its long-standing leadership in the premium category, expanding its share to 59.5% of the segment. This performance highlights the enduring strength of Altria’s flagship brand and ability to defend profitability even in a challenging industry environment.
Still, investors must weigh ongoing risks. Domestic cigarette shipments fell 10.2% in the second quarter of 2025, reflecting the broader industry downturn as flavored disposable e-vapor products capture share, compounded by discretionary income pressures on adult tobacco consumers.
The Case for Philip Morris
Philip Morris’ growth story remains firmly anchored in its smoke-free transformation. In the second quarter of 2025, smoke-free products accounted for 41% of total net revenues, improving 15.2% year over year and 14.5% organically, with strong contributions from IQOS, ZYN and VEEV. This segment has become an increasingly important contributor to earnings, positioning PM for sustainable growth and long-term value creation.
Despite volume declines, PM’s traditional cigarette business remains resilient, supported by its premium brands and pricing power. Combustible net revenues grew 2.1% in the second quarter, driven by price increases, while the gross profit advanced 5%. Marlboro also reached its highest quarterly market share since the 2008 spin-off, reinforcing PM’s brand strength and pricing leadership.
Philip Morris also advanced its cost and productivity initiatives. The company achieved more than $500 million in gross cost savings in the first half of the year through manufacturing and back-office optimization initiatives. The company aims to deliver $2 billion in gross cost efficiencies between 2024 and 2026, and by mid-2025, it has already realized more than $1.2 billion. The margin expansion achieved in the quarter reflects the impacts of these efficiencies.
Management recently lifted its full-year adjusted EPS guidance to $7.43-$7.56 (indicating 13-15% growth) from the prior stated $7.36-$7.49 (implying 12-14% growth). This guidance reflects confidence in sustaining double-digit earnings growth, although regulatory and currency challenges persist.
However, challenges remain in Philip Morris’ combustible business. Cigarette shipment volumes declined 1.5% year over year to 155.2 billion units in the second quarter, with notable weakness in Turkey and Indonesia. Management foresees a 2% cigarette volume decrease for the full year, with a sharper 3-4% drop in the second half.
How Does the Zacks Consensus Estimate Compare for MO & PM?
The Zacks Consensus Estimate for Altria’s 2025 EPS has moved up by 2 cents over the last 30 days to $5.39, implying a year-over-year increase of 5.3%. In comparison, the consensus estimate for Philip Morris has remained unchanged at $7.50 during the same period and points to growth of 14.2% for 2025.
Price Performance & Valuation of MO & PM
Altria stock has advanced 15.2% in the past month, outperforming Philip Morris, which gained 8.9%, and the broader industry’s 11.3% growth, underscoring investor confidence in Altria’s strategy and execution.
On the valuation front, Altria trades at a forward P/E multiple of 12.29, attractive for yield-focused investors, while Philip Morris carries a premium 21.25 multiple, backed by its global scale and smoke-free momentum.
Image Source: Zacks Investment Research
Bottom Line: PM Is the Better Bet
While both Altria and Philip Morris offer compelling cases, the balance tilts in favor of Philip Morris as the stronger long-term investment. Its global scale, leadership in smoke-free innovation and accelerating transformation toward reduced-risk products give it an edge in navigating the tobacco industry’s structural changes. Altria remains attractive for income-oriented investors, but Philip Morris emerges as the better bet for sustained growth and future value creation.
Image: Bigstock
Altria vs. Philip Morris: Which Stock Smokes Out Better Returns?
Key Takeaways
Altria Group, Inc. ((MO - Free Report) ) and Philip Morris International Inc. ((PM - Free Report) ) stand as two of the most recognized names in the global tobacco industry. While Altria primarily operates within the United States, Philip Morris International has built its dominance outside the United States. Both companies are rooted in the manufacture and sale of cigarettes, smokeless tobacco and increasingly, next-generation reduced-risk products aimed at adapting to shifting consumer preferences and regulatory pressures.
The tobacco industry itself is undergoing a major transformation, shaped by declining cigarette volumes, rising health awareness and evolving regulatory frameworks. Companies like MO and PM are not only competing on brand strength but also on their ability to innovate through alternatives such as heated tobacco and nicotine pouches.
One-Year Price Performance
Image Source: Zacks Investment Research
The Case for Altria
A key driver of Altria’s investment appeal is its resilient earnings growth. In the second quarter of 2025, adjusted earnings per share (EPS) rose 8.3% year over year to $1.44, supported by higher pricing, cost efficiencies and share repurchases. Revenues net of excise taxes held firm at $5.29 billion, reinforcing portfolio stability. Based on the performance, management raised the lower end of its 2025 adjusted EPS guidance to $5.35-$5.45, representing a growth rate of 3% to 5%.
Momentum in the oral tobacco segment remains a standout catalyst, led by the on! nicotine pouch brand. Shipments of on! rose 26.5% to 52.1 million cans in the second quarter. on! now holds 8.7% retail share of the total U.S. oral tobacco market, supported by digital marketing and brand activations that improved consumer awareness. This success drove a 10.9% increase in adjusted operating income and a margin expansion of 310 bps to 68.7%, underscoring Altria’s smoke-free growth strategy.
Meanwhile, Altria’s smokeable products segment continues to demonstrate resilience, driven by strong pricing and disciplined brand management. The adjusted operating income rose 4.2% in the second quarter, with margins expanding 290 bps to 64.5%. Marlboro maintained its long-standing leadership in the premium category, expanding its share to 59.5% of the segment. This performance highlights the enduring strength of Altria’s flagship brand and ability to defend profitability even in a challenging industry environment.
Still, investors must weigh ongoing risks. Domestic cigarette shipments fell 10.2% in the second quarter of 2025, reflecting the broader industry downturn as flavored disposable e-vapor products capture share, compounded by discretionary income pressures on adult tobacco consumers.
The Case for Philip Morris
Philip Morris’ growth story remains firmly anchored in its smoke-free transformation. In the second quarter of 2025, smoke-free products accounted for 41% of total net revenues, improving 15.2% year over year and 14.5% organically, with strong contributions from IQOS, ZYN and VEEV. This segment has become an increasingly important contributor to earnings, positioning PM for sustainable growth and long-term value creation.
Despite volume declines, PM’s traditional cigarette business remains resilient, supported by its premium brands and pricing power. Combustible net revenues grew 2.1% in the second quarter, driven by price increases, while the gross profit advanced 5%. Marlboro also reached its highest quarterly market share since the 2008 spin-off, reinforcing PM’s brand strength and pricing leadership.
Philip Morris also advanced its cost and productivity initiatives. The company achieved more than $500 million in gross cost savings in the first half of the year through manufacturing and back-office optimization initiatives. The company aims to deliver $2 billion in gross cost efficiencies between 2024 and 2026, and by mid-2025, it has already realized more than $1.2 billion. The margin expansion achieved in the quarter reflects the impacts of these efficiencies.
Management recently lifted its full-year adjusted EPS guidance to $7.43-$7.56 (indicating 13-15% growth) from the prior stated $7.36-$7.49 (implying 12-14% growth). This guidance reflects confidence in sustaining double-digit earnings growth, although regulatory and currency challenges persist.
However, challenges remain in Philip Morris’ combustible business. Cigarette shipment volumes declined 1.5% year over year to 155.2 billion units in the second quarter, with notable weakness in Turkey and Indonesia. Management foresees a 2% cigarette volume decrease for the full year, with a sharper 3-4% drop in the second half.
How Does the Zacks Consensus Estimate Compare for MO & PM?
The Zacks Consensus Estimate for Altria’s 2025 EPS has moved up by 2 cents over the last 30 days to $5.39, implying a year-over-year increase of 5.3%. In comparison, the consensus estimate for Philip Morris has remained unchanged at $7.50 during the same period and points to growth of 14.2% for 2025.
Price Performance & Valuation of MO & PM
Altria stock has advanced 15.2% in the past month, outperforming Philip Morris, which gained 8.9%, and the broader industry’s 11.3% growth, underscoring investor confidence in Altria’s strategy and execution.
On the valuation front, Altria trades at a forward P/E multiple of 12.29, attractive for yield-focused investors, while Philip Morris carries a premium 21.25 multiple, backed by its global scale and smoke-free momentum.
Image Source: Zacks Investment Research
Bottom Line: PM Is the Better Bet
While both Altria and Philip Morris offer compelling cases, the balance tilts in favor of Philip Morris as the stronger long-term investment. Its global scale, leadership in smoke-free innovation and accelerating transformation toward reduced-risk products give it an edge in navigating the tobacco industry’s structural changes. Altria remains attractive for income-oriented investors, but Philip Morris emerges as the better bet for sustained growth and future value creation.
MO and PM currently carry a Zacks Rank #3 (Hold) each. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.